chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling from knees down including feet on both legs.  Chronic cough.  Joint pain all over.  Redness and swelling of lower arms and hands.  Extreme tiredness.
Vaccine administered 2-8-06. Present to urgent care with injection site red, hard and swollen.
Patient Prevnar 20 two times one month apart, first dose give 8/29/22 and 2nd dose given 9/23/22
Developed 4 spots on forehead that looked like Herpes Zoster.  Had received on 1/4 and dermatitis occurred on 1/12/08 in 1st bunch of trigeminal, no distribution.  HP obtained from patient a retired physician.
Red rash on right arm around injection site about 2 inches by 3 inches. Rash was sore to the touch for 2 days and then remained after 10 days when she came into the pharmacy to report it.
Allergies, Asthma-Like illness, Muscle spasms/cramps,Blood/water painful Blisters on feet,ED,Infertility,anorgasmia,Bone/Joint Pain,Numbness/tingling from waist down/neuralgia, Receiving Asthma meds and treatments, seeing eurologist for sexuau dysfunctions,Had negatve chest x-ray, had negative covid-19 PCR test.
Beginning shortly after administration both date 3/12/20 and 7/15/20, patient vomited and became hyperexcitable for 2 days following vaccination
Immediate swelling/pain at injection site.  Swelling reducing at 10 min. post vaccine.
Admitted to hospital w/ headache, nausea, vomiting, cough, increasing SOB. Received Remdesivir.  Patient has a little headache and some nausea and now with some sore throat, now all resolved.  Denies cough or shortness of breath.  Currently on room air.  Infectious Disease on board.   completed remdesivir for 3 days per ID
recipient is age 16 and Moderna is approved for those 18 and older.  No adverse effects reported.
This nurse gave pediatric Hep A vaccine vs adult dose.  No adverse reactions have been noted.  Contacted pt and informed regarding error.
Approximately 10 minutes after receiving injection the patient reported nausea and a tingling sensation in the roof of her mouth. Vital signs stable. Complaining of severe headache a short time later. symptoms did not subside and thus following a physician's recommendation, this person was transferred by ambulance to the ED
Swelling and severe pain in shoulder and arm and had difficulty moving arm for next 30 hours.
Patient had no AE to the 1st Shingrix.  Patient AE started 2 hours after injection.  Dry heaves, diarrhea, hands wouldn't stop shaking, body aches all over, excessive sneezing, could hardly walk. Patient referred to Dr. Advised to take Tylenol. Patient slept. Patient feels a little better each day except joints hurt.
Temp 101 degrees F, chills, fatigue for 24 hours without other cause.
Onset of headache which became severe within 5 hours - onset of low-grade fever after 6 hours; onset of muscle weakness and tiredness/exhaustion which lasted FOUR DAYS!
Red patch with swelling in my arm below the injection place. Arm is swollen and felling nerve pain on my left hand from palm till shoulder.
My left arm  and shoulder through to my neck and hip developed severe pain, The hip pain resolved after 4 days but the arm pain an neck pain persisted keeping me awake. The shoulder has resolved this past week but I still have tremendous pain in left arm and have to take large amounts of Naproxen to keep it at a low. It keeps me awake at night
68 yo female s/p full Pfizer COVID vaccination: dose 1 on 2/18 and dose 2 on 3/11. Reports fatigue and possible exposure to COVID-19 on 8/3. PCR test results positive on 8/4. Pt receives casirivimab/imdevimab infusion on 8/5.
Extreme fatigue; Injection site soreness; Injection site itch; Minor headache; Exacerbated pain in arthritic SI joints; This is a spontaneous report from a contactable consumer (patient).   A 50-year-old non-pregnant female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right on 01Mar2021 14:00, at the age of 50-years-old, (Lot Number: 59267-1000-01) as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included Depression, Anxiety, Asthma, SI joint arthritis, obesity, migraines, and environmental allergies. The patient did not have COVID-10 prior the vaccination. Concomitant medications included bupropion hydrochloride (WELLBUTRIN); sertraline hydrochloride (ZOLOFT); modafinil; folic acid; and ibuprofen, all were taken for unspecified indication, start and stop date were not reported.  On 01Mar2021 20:30, the patient experienced extreme fatigue, injection site soreness, injection site itch, minor headache, and exacerbated pain in arthritic SI joints. The patient was not tested for COVID-19 post vaccination.  The outcome of the events was not recovered. No treatment was received for the events.  No follow up attempts are possible. No further information is expected.
Mom noticed (L) leg was swollen, red and warm that night. the next day the leg was very warm, hard, swollen and hurt. Patient also started with a fever. Mom went to urgent care and was told it was cellulitis and put on an antibiotic. Redness is down and no fever.
Just after two weeks of receiving the RSV vaccine I had an incident happen at my home with a possible reaction to the vaccine. after cleaning my bathroom floor with a strong solution of pine cleaner I experienced a strong burning in my lungs and rapid heartbeat for a short time. I waited until the following Sunday to go to the Urgent Care (I thought it might get better with time but didn't) with shortness of breath, lung/chest pain, the feeling of inadequate oxygen intake, etc. was then (the same day) transferred to ER for chest x-ray and heart monitoring, then released six hours later. I had a follow up this morning at Dr office and told them of my continuing lung problems and have been prescribed steroids with follow up chest ultrasound yet to be scheduled. Note: I've used pine cleaners for years and never had such an intense reaction before. I've since read about possible lung inflammation from the RSV vaccine and wondered if the vaccine might have inflamed my lung tissues and greatly magnified my reaction. I was told by one medical provider that it might be chemically induced bronchitis. If you all receive any reports of chemically induced bronchitis or pneumonia from recently RSV vaccinated patients, please research a possible adverse reaction connection. Thank you!
Arthus reaction, onset 1/6/2021, sore throat, malaise, fatigue, anorexia. Onset of constitutional symptoms 12 hours prior to skin changes at injection site. Initially, erythematous indurated, painful area at injection site about 1 inch diameter. Involved area increased in size daily. Erythema remained. Induration and pain resolved. Intermittent pruritis at the site. 1/11/21 , erythematous, non indurated, with central clearing area 10 x 6 inch with well demarcated margins. 1/12/21, mild ecchymosis centrally. Constitutional symptoms improved, but not resolved.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 27-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
flu like symptoms for 48 hours, fatigue, sore arm at injection site, rash possibly related.
Hives that began underneath upper arms and on upper thighs. Hives spread to entire arms and legs and abdomen. Hives did not respond to antihistamines or steroids. Hives lasted 6 weeks.
Child went to day care after clinic appt. Day care called mother that afternoon to report that child was running fever and that he held his breath until he lost consciousness (maybe a minute). Lips turned blue. While unconsciousness, was shaking. Eyes rolled back in head. Was crying and upset when he woke up. Mother reported all of this through what the day care reported to her. Was not with child when event happened. Mom stated he had fever but uncertain of number. Gave TYLENOL. Spoke with mother on 6/7/12. States that patient has had no more episodes and is doing good. No more fever.
COVID-19; Mental disorder/Mental issue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) and MENTAL DISORDER (Mental disorder/Mental issue) in an adult male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect products included non-company products ADALIMUMAB (HUMIRA) for an unknown indication and USTEKINUMAB (STELARA) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form, ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose and USTEKINUMAB (STELARA) (unknown route) at an unspecified dose. On an unknown date, the patient experienced COVID-19 (COVID-19) and MENTAL DISORDER (Mental disorder/Mental issue). At the time of the report, COVID-19 (COVID-19) and MENTAL DISORDER (Mental disorder/Mental issue) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information was not reported.  Company Comment:  This is a spontaneous case concerning an adult male patient of unspecified age with concomitant medication of Adalimumab and Ustekinumab as co-suspect drugs, who experienced the unexpected non-serious  adverse event of special interest COVID-19, in the context of a dose of mRNA-1273 vaccine. Latency cannot be properly assessed since vaccination date nor event onset date were provided. The patient also experienced mental disorder described as mental issues. No further details about the clinical course, diagnostic procedures and treatments were provided. Outcome of the events were unknown. The co-suspect drugs Adalimumab and Ustekinumab, which are immunosuppressant, increases the susceptibility of patient to acquire COVID-19 infection. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This is a spontaneous case concerning an adult male patient of unspecified age with concomitant medication of Adalimumab and Ustekinumab as co-suspect drugs, who experienced the unexpected non-serious  adverse event of special interest COVID-19, in the context of a dose of mRNA-1273 vaccine. Latency cannot be properly assessed since vaccination date nor event onset date were provided. The patient also experienced mental disorder described as mental issues. No further details about the clinical course, diagnostic procedures and treatments were provided. Outcome of the events were unknown. The co-suspect drugs Adalimumab and Ustekinumab, which are immunosuppressant, increases the susceptibility of patient to acquire COVID-19 infection. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Body aches, chills, 101 fever overnight. Treated with Tylenol. The next day a lump appeared under the vaccinated arm (in the armpit), which is tender. Vaccine site is very sore when arm is moved.  Now it?s day 3 and the vaccine site is still sore and the lump in armpit is still there.
This spontaneous report was received from a medical assistant and refers to unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unspecified dates in 2016, on or after 14-JAN-2016, the patients were vaccinated with improperly stored doses of ROTATEQ (exact dose was not reported, lot # reported as L023866 and L028366, expiration date 24-MAR-2017), orally. No adverse effects were reported. The administered doses of ROTATEQ experienced a temperature excursion of 34 Fahrenheit degrees (F) for 25 hours. The doses were not exposed for the previous temperature excursion. Additional information has been requested.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose :01/08/21pfizer,Lot# 2nd dose: 01/29/21,Pfizer,Lot#  Diagnosed covid positive:07/16/21 Exposure: Symptoms:Fever, head ache.
Initial report received from a patient on 15 March 2007. A 73 year old, female patient complained of "pressure on chest" and "feeling indigestion", approximately 6 hours (1010 PM) after she received Fluzone (lot number, site and date of administration unknown) intramuscularly in November 2006 at 4PM. The symptoms lasted approximately 2 hours then subsided. She had never experienced this prior to or after this event. She received Fluzone 2 years prior. At the time of the vaccination, she denied any illness and was taking Natalol. She was not treated with any medications. It was reported that she recovered. Follow up information received from a consumer, the patient on 20 July 2007: The patient had her first flu shot (an unspecified manufacturer) on November 2004, given on the side of the arm. The next day she experienced severe injection site swelling about 3" x 3". In the middle of November 2006, she received another flu shot (Fluzone), approximately at 16:00 hours. At about 22:00 hours she started shivering, felt cool with no fever. Then experienced slight pressure on the chest and feeling of indigestion. She was able to breathe normally. The patient never felt like this before. It subsided after 2 hours, she fell asleep and woke up fine the next morning. The patient was taking Nadolol (previously reported as Natalol) as concomitant medication.
Developed heart palpitations night of 12/7/21, self-monitored to see if they resolved. Then developed chest pain in addition to palpitations on 12/12/21 and went to Urgent Care for assessment and was advised to monitor symptoms. Returned for follow-up care at the Medical Center under advisement of my primary care physician for diagnostic testing for continued chest pain and palpitations on 12/13/21. Underwent blood testing and EKG and told to return if symptoms persisted. Returned to the Medical Urgent Care/PCP care on 12/15/21 and 12/17/21 for worsening chest pain and continued palpitations. Underwent repeat EKG and blood testing, chest x-ray. Prescribed Indomethacin and colchicine and referred to cardiology for diagnosis of pericarditis due to adverse vaccine reaction. Onset of severe dizziness and lightheadedness on 12/19/21 and had been told to seek urgent care for any new or worsening symptoms. Went to the Emergency Room and underwent EKG, bloodwork and echocardiogram. Had an appt. with a cardiologist on 12/21/21 and was diagnosed with acute pericarditis from adverse vaccine reaction. Heart palpitations continued for 3 weeks post-vaccine. Intermittent chest and thoracic pain continue.
Site of puncture was sore. Then started to itch badly and became bright pink. Had an appt. with my dermotologist July 7 and showed it to him.  He reported it to Dr. and gave me some cream which stopped the itching.  Today, July 9th it doesn't itch anymore and the color is fading.
no adverse event; HCP reported GARDASIL 9 was administered to a pregnant patient. Caller did not provide any further clarifying details; This spontaneous report was received from a nurse referred to a 29-year-old female patient. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported.   On an unknown date, the patient became pregnant. The pregnancy gestation was reported as 29 weeks and 2 days. The last menstrual period (LMP) was estimated was on 20-AUG-2022. On 13-MAR-2023, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter, lot #1775811, expiration date: 07-DEC-2023, administered intramuscularly for prophylaxis (strength was not provided) (exposure during pregnancy). The reporter did not provide any further clarifying details. No additional adverse event was reported (No adverse event). The pregnancy outcome was pending and the fetal outcome was unknown at the time of the report. The estimated date of delivery (EDD) was calculated on 27-MAY-2023.
Site: Pain at Injection Site-Medium, Systemic: shooting pain on left arm-Severe, Systemic: Tachycardia-Severe, Additional Details: palpitation, call to pharmacy that left hospita today after being hospital since thursday, they wanted to complete a ekg and stress test and refused, will consult wqith doctor and insurance, still not feeling well.
vaccine given to patients without reaching room temperature; vaccine given to patients without reaching room temperature; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given to patients without reaching room temperature) and PRODUCT STORAGE ERROR (vaccine given to patients without reaching room temperature) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given to patients without reaching room temperature). On 31-Mar-2021, the patient experienced PRODUCT STORAGE ERROR (vaccine given to patients without reaching room temperature). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine given to patients without reaching room temperature) and PRODUCT STORAGE ERROR (vaccine given to patients without reaching room temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.      Reporter did not allow further contact
Attack of vertigo and nausea on waking up. Taken meclizine 25mg tablet at 7:00am and another at 2:00pm. Ok for one day then more vertigo on 12/17/09 at 4:00am. Taken 2 more meclizine. No fever.
There was a granuloma on my left clavicle. First noticed in the beginning of May. Developed very rapidly. Had a needle biopsy on June 7th. That came back negative. Had most of the granuloma surgically removed on June 16th. And the lab work came back negative on everything we tested. It was a golf ball so they had plenty of test. At hospital - outpatient.  I actually feel better than I did a month ago and it's making my doctor crazy because he doesn't know what caused it and I have no new symptoms to give to him. Will see an immunologist (my primary) next week. We'll decide if there are other things he wants to test for or treat. About 30% of the granuloma remains and there is still some drainage of fluid from it.
mild sore throat; This is a spontaneous report from a contactable consumer(patient).  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0177), via an unspecified route of administration on an unspecified date, as unknown, single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced mild sore throat. The consumer stated, the patient experienced some mild sore throat not too bad but just a little mild since I have received the vaccine. The outcome of the mild sore throat was unknown.
Woke at 4am with chills. Temperature 101.1F temporal.  Otherwise feeling ok. Just drinking fluids.
At 10:15AM patient complained of "strange feeling in throat" Patient denied chest pain or shortness of breath.  No swelling or rash noted.  Patient given water at 10:20 and apple juice at 10:25.  Patient rested on stretcher until 10:32.  Patient stated she felt better and her throat sensation resolved.  Patient discharged and patient's father drove her home.
This spontaneous report was received from a pharmacist concerning a patient from an unspecified nursing home. (No patient demographics provided). On 24-FEB-2014, patient was vaccinated with a dose of PNEUMOVAX 23, injection (Lot: H010916; Exp. Date: 15-FEB-2014) (Dose, route and strength not provided). Co-suspect or concomitant therapies were not reported. The pharmacist reported the patient that was vaccinated with an expired PNEUMOVAX 23 vaccine. No adverse effects were reported. Additional information has been requested.
AFTER RECEIVING THE VACCINE SHE STARTED COMPLAINING OF DIZZINESS AND LIGHTHEADINESS. ON SITE EMS RESPONDED. VITALS ARE BELOW. SHE WAS TREATED AND RELEASED TO HOME
DID NOT THINK I WAS GOING TO THE SHOULDER BEFORE PASSING OUT; WHILE DRIVING ON A 6 LANE HIGHWAY HAD WHAT FELT LIKE A STROKE; This spontaneous report received from a patient via a social media via a company representative concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total was administered for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. It was reported by the reporter that, on an unspecified date, "two days later while driving on a 6 lane highway had what felt like a stroke did not think I was going to the shoulder before passing out. No more for me I'll take my chances with covid" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the did not think i was going to the shoulder before passing out and while driving on a 6 lane highway had what felt like a stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211259090- JANSSEN COVID-19 VACCINE Ad26.COV2.S- Did not think I was going to the shoulder before passing out. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Slight tingling in legs and arms. General weakening in knees legs as if you have no strength as if you do not control hands and feet. For 4 days but not all day. I exercised on the 5th day, stationary bike and with that I felt much better.  The next day I woke up better and I have done Yoga every day to feel better however the symptoms continued slightly.  I have another feeling that is as if my brain is disconnected is to say as if I am going to faint are very fast events but I go to bed and feel good. However, I have never fainted.
Daily headaches, nausea and vomiting, pale gray dry skin, bumps, lesions, eye infections, hair loss, insomnia, fatigue, fainting, muscle weakness, clumsy, brain fog, memory loss, night sweats, frequent infections, UTIs and yeast, sore throat, chest pain, sinus, limb numbness, tremors, irregular periods with excessive cramping and vomiting, constipation stomach and back pain, light sensitive, nosebleeds.
fever 102, earache, sore throat, chills, malaise, aching muscles, red stiff arm, vomiting; pt states felt ill for 2 wks but did not seek care;
Post vax, the pt experienced chills, stiff neck, and a sense of feeling paralyzed. All symptoms resolved sufficiently so that the pt was able to return to work the next day.